Related Experiment Video

Updated: Feb 28, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.7K

The Post-Pandemic Return of Mycoplasma pneumoniae: Why Children Matter and What Clinicians Should Know

Takeshi Saraya1

  • 1Department of Respiratory Medicine, Kyorin University School of Medicine, Tokyo 181-8611, Japan.

Journal of Clinical Medicine
|February 27, 2026
PubMed

Insights

Mycoplasma pneumoniae infections resurged after COVID-19 restrictions eased, with children driving community spread. Macrolide-resistant strains and PCR interpretation challenges impact management strategies.

Area of Science:

  • Pediatric infectious diseases
  • Epidemiology
  • Molecular diagnostics

Background:

  • COVID-19 non-pharmaceutical interventions (NPIs) temporarily reduced Mycoplasma pneumoniae infections.
  • Resurgence of M. pneumoniae observed post-lifting of NPIs.
  • Children identified as a significant reservoir for sustained community transmission.

Purpose of the Study:

  • Synthesize recent epidemiologic and molecular data on M. pneumoniae.
  • Highlight challenges in PCR interpretation due to asymptomatic carriage.
  • Discuss clinical implications of macrolide-resistant M. pneumoniae (MRMP) and management strategies.

Main Methods:

  • Narrative perspective synthesizing existing literature.
  • Review of epidemiologic trends and molecular observations.
  • Analysis of clinical implications and management considerations.

Main Results:

  • M. pneumoniae infections rebounded after COVID-19 NPIs were lifted.
  • Asymptomatic carriage and prolonged detection complicate PCR results.
  • Macrolide resistance in M. pneumoniae (MRMP) presents significant clinical challenges.

Conclusions:

  • Children are key reservoirs for M. pneumoniae transmission.
  • Pragmatic, age-stratified management is needed for MRMP.
  • Priorities include enhanced surveillance and simplified clinical pathways for MRMP.
Keywords:
Mycoplasma pneumoniaemacrolide resistancepediatric reservoirpost-COVID-19 resurgencerespiratory viral co-infection

More Related Videos

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae06:04

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae

Published on: February 24, 2023

2.9K
A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

3.2K

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.1K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
977
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.5K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.7K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
896
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.0K